|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 12 February 2003
doi: 10.1242/jcs.00301
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |
1 Institute of Molecular Pharmacology, D-13125 Berlin, Germany
2 ASCA Angewandte Synthesechemie Adlershof GmbH, 12489 Berlin, Germany
3 Department of Pathology, University of Tennessee Health Science Center,
Memphis, TN 38163, USA
* Author for correspondence (e-mail: aslominski{at}utmem.edu)
Accepted 2 December 2002
Using confocal laser scanning microscopy we investigated the Ca2+ distribution in single corticotropin releasing factor- and urocortin-stimulated human skin cells. The models tested included melanoma cells, neonatal melanocytes and keratinocytes, and immortalized HaCaT keratinocytes. The changes in intracellular Ca2+ signal intensities observed after stimulation of different cell types with corticotropin releasing factor and urocortin showed that: (1) the increase of intracellular Ca2+ concentration was caused by a Ca2+ influx (inhibition by EGTA); (2) this Ca2+ influx took place through voltage-activated Ca2+ ion channels (inhibition by d-cis-diltiazem, verapamil) and (3) cyclic nucleotide-gated ion channels were not involved in this process (no effect of Mg2+). The effects were also observed at very low peptide concentrations (10-13 M) with no apparent linear correlation between peptide dosage and increase of fluorescence intensity, which implied co-expression of different corticotropin releasing factor receptor forms in the same cell. Immortalized (HaCaT) keratinocytes exhibited the strongest differential increases of a Ca2+ fluorescence after peptide-stimulation. Corticotropin releasing factor induced Ca2+ flux into the cytoplasm, while urocortin Ca2+ flux into the nucleus with a remarkable oscillatory effect. The latter indicated the presence of an intracellular urocortin-induced signal transduction pathway that is unique to keratinocytes.
Key words: CRF, Urocortin, Keratinocytes, Melanocytes, Calcium signaling, Calcium oscillation
This article has been cited by other articles:
![]() |
S. Kauser, A. Slominski, E. T. Wei, and D. J. Tobin Modulation of the human hair follicle pigmentary unit by corticotropin-releasing hormone and urocortin peptides FASEB J, May 1, 2006; 20(7): 882 - 895. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cao, C. L. Cetrulo, and T. C. Theoharides Corticotropin-Releasing Hormone Induces Vascular Endothelial Growth Factor Release from Human Mast Cells via the cAMP/Protein Kinase A/p38 Mitogen-Activated Protein Kinase Pathway Mol. Pharmacol., March 1, 2006; 69(3): 998 - 1006. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Parham, S. Zervou, E. Karteris, R. D. Catalano, R. W. Old, and E. W. Hillhouse Promoter Analysis of Human Corticotropin-Releasing Factor (CRF) Type 1 Receptor and Regulation by CRF and Urocortin Endocrinology, August 1, 2004; 145(8): 3971 - 3983. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chen, A. Blount, J. Vaughan, B. Brar, and W. Vale Urocortin II Gene Is Highly Expressed in Mouse Skin and Skeletal Muscle Tissues: Localization, Basal Expression in Corticotropin-Releasing Factor Receptor (CRFR) 1- and CRFR2-Null Mice, and Regulation by Glucocorticoids Endocrinology, May 1, 2004; 145(5): 2445 - 2457. [Abstract] [Full Text] [PDF] |
||||